Search

Search Constraints

You searched for: Author/Creator Moss, Joel

Search Results

1. A genome-wide association study implicates NR2F2 in lymphangioleiomyomatosis pathogenesis. Issue 6 (27th June 2019)

3. ADP‐ribosyltransferases, an update on function and nomenclature. (13th September 2021)

4. Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis. Issue 4 (4th April 2019)

5. Assessment of Lung Structure and Regional Function Using 0.55 T MRI in Patients With Lymphangioleiomyomatosis. Issue 3 (March 2022)

9. Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial. Issue 5 (28th May 2020)

10. Cholix toxin, an eukaryotic elongation factor 2 ADP‐ribosyltransferase, interacts with Prohibitins and induces apoptosis with mitochondrial dysfunction in human hepatocytes. (14th May 2019)